Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTristel Regulatory News (TSTL)

Share Price Information for Tristel (TSTL)

Share Price is delayed by 15 minutes
Get Live Data
397.50    2.00 (0.51%)
Bid:
390.00
Ask:
405.00
Spread: 15.00 (3.846%)
Market Cap: £190.07m
TSTL Live PriceLast checked at - London Stock Exchange

Intraday Tristel Share Chart

Director Appointment

24 Dec 2020 07:00

RNS Number : 7336J
Tristel PLC
24 December 2020
 

Tristel plc

("Tristel" or the "Company")

 

Director Appointment

 

Tristel plc (AIM: TSTL), leading manufacturer of infection prevention products, announces the appointment of Caroline Stephens to the Board as an Independent Non-Executive Director effective from 1 January 2021.

 

Caroline's executive career has been spent in global healthcare, marketing, and digital transformation, working for Johnson & Johnson for 26 years in multiple leadership roles.

 

Caroline holds a board advisory role with global digital transformation consultants CI&T.

 

It is expected that Caroline will join Tristel's Audit, Remuneration and Nomination committees.

 

Commenting on the appointment, Paul Swinney, CEO of Tristel, said: "I am delighted to welcome Caroline to the Board at such an exciting time for our Company. Caroline has extensive international and sector experience and we very much look forward to working with her."

 

For further information please contact:

 

Tristel plc

Tel: 01638 721 500

Paul Swinney, Chief Executive Officer

 

Liz Dixon, Finance Director

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 or tristel@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 

 

finnCap

Tel: 020 7220 0500

Geoff Nash/ Giles Rolls (Corporate Finance)

 

Alice Lane (ECM)

 

   

 

 

Regulatory disclosure - The following information is disclosed in accordance with Rule 17 and paragraph (g) of Schedule 2 of the AIM Rules for Companies.

 

Caroline Jane Stephens, 53, holds no ordinary shares in the Company and no options. Caroline Stephen's current and previous directorships/partnerships are as follows:

 

Current Directorships/Partnerships:

Rex Bakery Ltd

Glendevon Trading Ltd

Verve Portfolio Ltd

 

Former Directorships/Partnerships held in last 5 years:

None

 

Save for the disclosures above, there are no further disclosures to be made in accordance with Rule 17 and Schedule 2(g) of the AIM Rules.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUOUVRROUUUAA
Date   Source Headline
18th Jan 20137:00 amRNSTristel Wipes System obtains approval in China
17th Jan 20137:00 amRNSPeer-reviewed published articles
11th Dec 201212:56 pmRNSResult of AGM
29th Oct 20127:00 amRNSFinal Results
29th Aug 20127:00 amRNSDirector/PDMR Shareholding
8th Aug 20127:00 amRNSDirectorate Change
2nd Aug 20127:00 amRNSNew website
23rd Jul 201210:29 amRNSDirector/PDMR Shareholding
23rd Jul 20127:00 amRNSTrading update
9th Jul 20127:00 amRNSSupply&distribution agreement - Basan Germany GmbH
25th Jun 20127:00 amRNSDirectorate Change
15th Jun 201211:40 amRNSDirectors' Shareholdings
15th Jun 20127:00 amRNSTrading Update
12th Jun 20127:00 amRNSResult of Clinical Study
30th Apr 20129:00 amRNSDirectors' Dealings
3rd Apr 20127:00 amRNSTermination of supply arrangement
30th Mar 20127:00 amRNSResults of Clinical Study
12th Mar 20127:00 amRNSHalf Yearly Report
8th Mar 20127:00 amRNSNotice of Results
11th Jan 20123:17 pmRNSDirector/PDMR Shareholding
4th Jan 20128:50 amRNSDirector/PDMR Shareholding
23rd Dec 201112:16 pmRNSDirector/PDMR Shareholding
21st Dec 20113:40 pmRNSGrant of Share Options
13th Dec 201111:52 amRNSResult of AGM
8th Dec 20114:24 pmRNSDirector/PDMR Shareholding
25th Nov 20111:22 pmRNSDirector/PDMR Shareholding
22nd Nov 20117:00 amRNSDirector's Dealing
11th Nov 201110:27 amRNSDirector/PDMR Shareholding
4th Nov 20112:10 pmRNSDirector/PDMR Shareholding
24th Oct 20119:51 amRNSDirector/PDMR Shareholding
24th Oct 20117:01 amRNSDirectorate Change
24th Oct 20117:00 amRNSFinal Results
7th Sep 20117:00 amRNSFull regulatory approval for Fuse and Jet in China
9th Aug 20118:37 amRNSDirector's Shareholding
8th Aug 20117:00 amRNSCash inflow regarding R&D spend
25th Jul 20117:00 amRNSTrading update & notice of results
6th Jun 20117:00 amRNSApproval for Wipes System from VAH in Germany
12th May 20118:00 amRNSChina Licence received
6th May 20117:00 amRNSDirector Dealing
4th May 20112:38 pmRNSDirector Dealing
4th May 20117:00 amRNSDirector/PDMR Shareholding
28th Apr 20112:08 pmRNSTrading Update
14th Mar 20117:00 amRNSHalf Yearly Report
31st Jan 20117:00 amRNSCompletion of Clean Room & Notice of Results
30th Dec 20107:00 amRNSTermination of Agreement with Clorox
14th Dec 201011:15 amRNSResult of AGM
22nd Nov 201010:12 amRNSResult of General Meeting
12th Nov 201010:55 amRNSDirector/PDMR Shareholding
8th Nov 20103:06 pmRNSDirector Shareholding
5th Nov 201011:32 amRNSPlacing to raise £3.9million

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.